New Research Links Early Retinal Nerve Damage to Blood Sugar Levels Below the Prediabetes Threshold
Study suggests diabetes-related eye and nerve changes may begin before conventional prediabetes criteria are reached.
Recent research using UK Biobank data found associations between retinal neurodegenerative changes and HbA1c levels below the current diagnostic threshold for prediabetes, raising questions about how early metabolic changes may affect the nervous system.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Diabetes is commonly associated with complications affecting the eyes, kidneys, nerves and cardiovascular system. Diabetic retinopathy is traditionally monitored as one of the major eye complications of prolonged high blood glucose.
The new findings are significant because they suggest that changes involving the retina's nervous tissue may potentially occur before a person reaches the conventional HbA1c threshold used to define prediabetes. Researchers observed associations between blood sugar measurements and retinal neurodegenerative changes.
The findings do not mean that everyone with slightly elevated blood glucose will develop diabetes-related eye disease. They instead raise the possibility that metabolic health may influence retinal and neurological tissues earlier than previously recognized.
If future studies confirm the relationship, earlier identification of metabolic risk could become increasingly important for preventing long-term complications involving vision and nerve health.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
